Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie B Spangler

Showing results (51-60 of 87) with videos related to

Pageof 9
Sort By:
Cell|February 19, 2021
Structural basis for IL-12 and IL-23 receptor sharing reveals a gateway for shaping actions on T versus NK cellsCaleb R Glassman, Yamuna Kalyani Mathiharan, Kevin M Jude, et al.
The Journal of Biological Chemistry|November 17, 2024
Production of site-specific antibody conjugates using metabolic glycoengineering and novel Fc glycovariantsZachary J Bernstein, Taylor R Gierke, Kris Dammen-Brower, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 2018
Engineering a Single-Agent Cytokine/Antibody Fusion That Selectively Expands Regulatory T Cells for Autoimmune Disease TherapyJamie B Spangler, Eleonora Trotta, Jakub Tomala, et al.
Matter|December 19, 2022
Supramolecular filaments for concurrent ACE2 docking and enzymatic activity silencing enable coronavirus capture and infection preventionCaleb F Anderson, Qiong Wang, David Stern, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Regulating IL-2 immune signaling function via a core allosteric structural networkClaire H Woodward, Shahlo O Solieva, Daniel Hwang, et al.
Journal of Molecular Biology|December 11, 2024
Regulating IL-2 Immune Signaling Function Via A Core Allosteric Structural NetworkClaire H Woodward, Shahlo O Solieva, Daniel Hwang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 16, 2022
Engineered bispecific antibodies targeting the interleukin-6 and -8 receptors potently inhibit cancer cell migration and tumor metastasisHuilin Yang, Michelle N Karl, Wentao Wang, et al.
Journal of Autoimmunity|October 16, 2023
Rapamycin nanoparticles increase the therapeutic window of engineered interleukin-2 and drive expansion of antigen-specific regulatory T cells for protection against autoimmune diseaseTakashi Kei Kishimoto, Max Fournier, Alicia Michaud, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 27, 2025
Bispecific receptor decoy proteins block ocular neovascularization via simultaneous blockade of vascular endothelial growth factor A and CPaul R Sargunas, Emily Ariail, Raquel Lima E Silva, et al.
Journal for Immunotherapy of Cancer|February 6, 2025
Single-chain variable fragment affinity tuning can optimize anti-AML CAR-NK cell functionalityRuyan Rahnama, Monika Kizerwetter, Huilin Yang, et al.
Pageof 9

Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
Cell|February 19, 2021
Structural basis for IL-12 and IL-23 receptor sharing reveals a gateway for shaping actions on T versus NK cellsCaleb R Glassman, Yamuna Kalyani Mathiharan, Kevin M Jude, et al.
The Journal of Biological Chemistry|November 17, 2024
Production of site-specific antibody conjugates using metabolic glycoengineering and novel Fc glycovariantsZachary J Bernstein, Taylor R Gierke, Kris Dammen-Brower, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 2018
Engineering a Single-Agent Cytokine/Antibody Fusion That Selectively Expands Regulatory T Cells for Autoimmune Disease TherapyJamie B Spangler, Eleonora Trotta, Jakub Tomala, et al.
Matter|December 19, 2022
Supramolecular filaments for concurrent ACE2 docking and enzymatic activity silencing enable coronavirus capture and infection preventionCaleb F Anderson, Qiong Wang, David Stern, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Regulating IL-2 immune signaling function via a core allosteric structural networkClaire H Woodward, Shahlo O Solieva, Daniel Hwang, et al.
Journal of Molecular Biology|December 11, 2024
Regulating IL-2 Immune Signaling Function Via A Core Allosteric Structural NetworkClaire H Woodward, Shahlo O Solieva, Daniel Hwang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 16, 2022
Engineered bispecific antibodies targeting the interleukin-6 and -8 receptors potently inhibit cancer cell migration and tumor metastasisHuilin Yang, Michelle N Karl, Wentao Wang, et al.
Journal of Autoimmunity|October 16, 2023
Rapamycin nanoparticles increase the therapeutic window of engineered interleukin-2 and drive expansion of antigen-specific regulatory T cells for protection against autoimmune diseaseTakashi Kei Kishimoto, Max Fournier, Alicia Michaud, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 27, 2025
Bispecific receptor decoy proteins block ocular neovascularization via simultaneous blockade of vascular endothelial growth factor A and CPaul R Sargunas, Emily Ariail, Raquel Lima E Silva, et al.
Journal for Immunotherapy of Cancer|February 6, 2025
Single-chain variable fragment affinity tuning can optimize anti-AML CAR-NK cell functionalityRuyan Rahnama, Monika Kizerwetter, Huilin Yang, et al.
Pageof 9